Difference between revisions of "Antimicrobial prophylaxis"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "5 PubMed" to "5/ PubMed") |
Warner-admin (talk | contribs) m (Text replacement - "6 PubMed" to "6/ PubMed") |
||
| Line 4: | Line 4: | ||
==ASCO/IDSA== | ==ASCO/IDSA== | ||
* '''2018:''' Taplitz et al. [https://doi.org/10.1200/JCO.18.00374 Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update] [https://pubmed.ncbi.nlm.nih.gov/30179565/ PubMed] | * '''2018:''' Taplitz et al. [https://doi.org/10.1200/JCO.18.00374 Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update] [https://pubmed.ncbi.nlm.nih.gov/30179565/ PubMed] | ||
| − | * '''2018:''' Taplitz et al. [https://doi.org/10.1200/JCO.2017.77.6211 Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update] [https://pubmed.ncbi.nlm.nih.gov/29461916 PubMed] | + | * '''2018:''' Taplitz et al. [https://doi.org/10.1200/JCO.2017.77.6211 Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update] [https://pubmed.ncbi.nlm.nih.gov/29461916/ PubMed] |
===Older=== | ===Older=== | ||
Revision as of 11:51, 2 May 2023
This is a stub page that will be expanded over time
Guidelines
ASCO/IDSA
- 2018: Taplitz et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update PubMed
- 2018: Taplitz et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update PubMed